Editorial: Moving beyond the molecular mechanisms of malignant pleural mesothelioma: Cues for novel biomarkers and drug targets

Ilaria Cavallari; Ferdinando Cerciello; Elisa Giovannetti; Loredana Urso

doi:10.3389/fonc.2023.1163144

Editorial: Moving beyond the molecular mechanisms of malignant pleural mesothelioma: Cues for novel biomarkers and drug targets

Ilaria Cavallari^*, Ferdinando Cerciello^*, Elisa Giovannetti^*, Loredana Urso^*

^*Corresponding author for this work

Research output: Contribution to journal › Editorial › Academic › peer-review

Original language	English
Article number	1163144
Journal	Frontiers in Oncology
Volume	13
DOIs	https://doi.org/10.3389/fonc.2023.1163144
Publication status	Published - 2023

Access to Document

10.3389/fonc.2023.1163144

Cite this

@article{97d1c5a4e79b41b1b8deaf003cc770bd,

title = "Editorial: Moving beyond the molecular mechanisms of malignant pleural mesothelioma: Cues for novel biomarkers and drug targets",

keywords = "MPM, biomarkers, data-repository, omics data analysis, target therapies",

author = "Ilaria Cavallari and Ferdinando Cerciello and Elisa Giovannetti and Loredana Urso",

year = "2023",

doi = "10.3389/fonc.2023.1163144",

language = "English",

volume = "13",

journal = "Frontiers in Oncology",

issn = "2234-943X",

publisher = "Frontiers Media S.A.",

}

TY - JOUR

T1 - Editorial

T2 - Moving beyond the molecular mechanisms of malignant pleural mesothelioma: Cues for novel biomarkers and drug targets

AU - Cavallari, Ilaria

AU - Cerciello, Ferdinando

AU - Giovannetti, Elisa

AU - Urso, Loredana

PY - 2023

Y1 - 2023

KW - MPM

KW - biomarkers

KW - data-repository

KW - omics data analysis

KW - target therapies

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85150509039&origin=inward

UR - https://www.ncbi.nlm.nih.gov/pubmed/36950549

U2 - 10.3389/fonc.2023.1163144

DO - 10.3389/fonc.2023.1163144

M3 - Editorial

C2 - 36950549

SN - 2234-943X

VL - 13

JO - Frontiers in Oncology

JF - Frontiers in Oncology

M1 - 1163144

ER -

Editorial: Moving beyond the molecular mechanisms of malignant pleural mesothelioma: Cues for novel biomarkers and drug targets

Access to Document

Other files and links

Cite this